Skip to main content

Table 1 Changes of liver function indexes and liver volume before and after PVE (M(IQR))

From: Application of hepatic lobe hyperplasia techniques in the treatment of advanced hepatic alveolar echinococcosis: a single-centre experience

Variables

Before PVE

After PVE

Z value

P value

TBil (μmol/L)

12.99 (7.94–28.27)

16.06 (10.84–31.08)

− 0.973

0.331

Alb (g/L)

36.65 (35.59–38.55)

36.48 (33.17–39.78)

− 0.94

0.925

AST (U/L)

28.75 (23.82–59.60)

40.13 (24.28–102.05)

− 1.412

0.158

ALT (U/L)

43.92 (23.08–78.78)

59.13 (23.91–147.74)

− 1.852

0.064

GGT (U/L)

159.65 (69.06–273.95)

107.00 (56.03–153.35)

− 0.664

0.507

TLV (cm3)

1910.76 (1453.60–3218.46)

1889.50 (1646.28–2792.19)

− 0.785

0.433

LV (cm3)

750.05 (335.73–1403.56)

582.41 (344.85–1087.09)

− 0.847

0.397

FLRV (cm3)

471.34 (306.92–685.78)

794.90 (636.08–1188.28)

− 3.296

0.001*

FLRV/TLV (%)

23.49 (17.61–27.82)

38.81 (35.78–46.93)

− 3.296

0.001*

  1. PVE portal vein embolization, TBil total bilirubin, Alb albumin, AST aspartate transaminase, ALT alanine aminotransferase, GGT gamma-glutamyl transpeptidase, TLV total liver volume, LV lesions volume, FLRV future liver remnant volume